the present invention is directed to luminal stent devices including vascular devices that comprise a specific polyphosphazene and the capability of releasing nitric oxide or other smooth muscle relaxant compounds in vivo or into stored or transient flowing blood to achieve vascular dilatation , reduce adverse reactions , reduce thrombosis , and / or to maintain the patency of a desired anatomic lumen .